Crossover from coherent to incoherent electronic excitations in the normal state of Bi(2)Sr(2)CaCu(2)O(8+delta)

Angle resolved photoemission spectroscopy (ARPES) and resistivity measurements are used to explore the overdoped region of the high temperature superconductor Bi(2)Sr(2)CaCu(2)O(8+delta). We find evidence for a new crossover line in the phase diagram between a coherent metal phase, for lower temperatures and higher doping, and an incoherent metal phase, for higher temperatures and lower doping. The former is characterized by two well-defined spectral peaks in ARPES due to coherent bilayer splitting and superlinear behavior in the resistivity, whereas the latter is characterized by a single broad spectral feature in ARPES and a linear temperature dependence of the resistivity.

Hall effect in nested antiferromagnets near the quantum critical point

We investigate the behavior of the Hall coefficient in the case of antiferromagnetism driven by Fermi-surface nesting, and find that the Hall coefficient should abruptly increase with the onset of magnetism, as recently observed in vanadium doped chromium. This effect is due to the sudden removal of flat portions of the Fermi surface upon magnetic ordering. Within this picture, the Hall coefficient should scale as the square of the residual resistivity divided by the impurity concentration, which is consistent with available data.

Dispersion anomalies in bilayer cuprates and the odd symmetry of the magnetic resonance

We demonstrate that recent angle resolved photoemission data in bilayer cuprate superconductors imply that scattering of electrons between bonding and antibonding bands is strong compared to scattering within these bands. As a consequence, the resulting data can be reproduced only by a model which assumes that the electrons are interacting with a bosonic mode that is odd with respect to the layer indices. This odd symmetry is a unique property of the magnetic resonance observed by inelastic neutron scattering.

Neutron resonance in the cuprates and its effect on fermionic excitations

We argue that the exciton scenario for the magnetic resonance in the cuprate superconductors yields a small spectral weight of the resonance, in agreement with experiment. We show that the small weight is related to its concentration in a small region of momentum and energy. Despite this, we find that a large fermionic self-energy can indeed be generated by a resonance with such properties, i.e., the scattering from the resonance substantially affects the electronic properties of the cuprates below T(c).

Renormalization of spectral line shape and dispersion below Tc in Bi2Sr2CaCu2O8+delta

Angle-resolved photoemission data in the superconducting state of Bi2Sr2CaCu2O8+delta show a kink in the dispersion along the zone diagonal, which is related via a Kramers-Krönig analysis to a drop in the low energy scattering rate. As one moves towards (pi,0), this kink evolves into a spectral dip. The occurrence of these anomalies in the dispersion and line shape throughout the zone indicates the presence of a new energy scale in the superconducting state.

Neutron resonance: modeling photoemission and tunneling data in the superconducting state of Bi2Sr2CaCu2O8+delta

Motivated by neutron scattering data, we develop a model of electrons interacting with a magnetic resonance and use it to analyze angle resolved photoemission and tunneling data in the superconducting state of Bi(2)Sr(2)CaCu(2)O(8+delta). We not only can explain the peak-dip-hump structure observed near the (pi,0) point, and its particle-hole asymmetry as seen in superconductor-insulator-normal tunneling spectra, but also its evolution throughout the Brillouin zone, including a velocity "kink" near the d-wave node.

Fermi surface of Bi2Sr2CaCu2O8

We study the Fermi surface of Bi2Sr2CaCu2O8 using angle resolved photoemission spectroscopy (ARPES) with a momentum resolution of approximately 0.01 of the Brillouin zone. We show that, contrary to recent suggestions, the ARPES derived Fermi surface is a large hole barrel centered at (pi,pi), independent of the incident photon energy. We caution that the photon energy and k dependence of the matrix elements, if not properly accounted for, can lead to misinterpretation of ARPES intensities.

Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo

Glucocorticoid resistance was investigated in human leukemic CCRF-CEM cells. A mutation (L753F), which renders the human glucocorticoid receptor (hGR) gene functionally hemizygous, was identified in all CEM-derived cell lines analyzed. Allele-specific PCR identified the same mutation in lymph node biopsy material from patient CEM cells. Given the correlation between hGR concentration and glucocorticoid sensitivity, this suggests that loss of functional heterozygosity may result in resistance to glucocorticoid-based chemotherapy. The L753F mutation was probably not responsible for the ontogeny of the disease because it did not appear to be present in all leukemic cells. Thus, it is unlikely that hGR mutations would be detected in leukemic patients at presentation, but they may occur, and be selected for, during treatment. Deletions and point mutations in the hGR gene of cells selected for steroid resistance in vitro were investigated by PCR-single strand conformation polymorphism analysis. Loss of hGR mRNA expression resulted from 5'-deletion of the hGR gene and nonsense mutations in exon 6. These results provide the first evidence for somatic mutation in the hGR gene of a patient with acute lymphoblastic leukemia, offer a potential in vivo mechanism for acquisition of steroid resistance in leukemia, and suggest that screening for additional in vivo mutations will require analysis of genomic DNA.

The human growth hormone receptor gene - characterisation of the liver-specific promoter

Several variants (V1-V8) have been described for the 5' untranslated region of human growth hormone receptor cDNA (Pekhletsky, R.I., Chernov B.K., Rubtsov, P.M., 1992. Variants of the 5'-untranslated sequence of human growth hormone receptor mRNA. Mol. Cell. Endocrinol. 90, 103-109). Transcription of one of these, variant V1, is under the control of a liver-specific promoter (Zou, L., Burmeister L.A., Sperling, M.A., 1997. Isolation of a liver-specific promoter for human growth hormone receptor gene. Endocrinology 138, 1771-1774). Further characterisation of this promoter shows that: (1) a cluster of exon 1 variants, which includes that coding for V1, is located about 13 kb upstream of the first coding exon; (2) the human V1 promoter (and not V7, as previously suggested) is homologous to liver-specific regulatory regions of rat and mouse GH receptor genes; (3) the transcription start site for V1 is 27 bp further upstream than previously reported; (4) a 158-bp sequence is sufficient for basal promoter activity, while larger constructs provide evidence for negative elements further upstream; and (5) nuclear proteins from HepG2 hepatoma cells protect regions of the V1 promoter from DNase digestion, revealing putative regulatory sites.

Quasiparticles in the superconducting state of Bi(2)Sr(2)CaCu(2)O(8+delta)

Recent improvements in momentum resolution lead to qualitatively new angle-resolved photoemission spectroscopy results on the spectra of Bi(2)Sr(2)CaCu(2)O(8+delta) (Bi2212) along the (pi,pi) direction, where there is a node in the superconducting gap. We now see the intrinsic line shape, which indicates the presence of true quasiparticles at all Fermi momenta in the superconducting state, and lack thereof in the normal state. The region of momentum space probed here is relevant for charge transport, motivating a comparison of our results to conductivity measurements by infrared reflectivity.

Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells

Interaction of epithelial cells with the extracellular matrix is mediated through integrin receptors, which transmit signals regulating cell growth, differentiation and death. Occupation of these receptors, via Arg-Gly-Asp (RGD) recognition sequences, leads to activation of focal adhesion kinase (FAK). We treated human breast cancer cell lines with RGD-containing peptides, which can disrupt integrin attachment, and investigated alterations in FAK phosphorylation, cell detachment and death. Cells grown in vitro were treated with insulin-like growth factor-binding protein-1 (IGFBP-1) and a small, synthetic RGD-containing peptide (Gly-Arg-Gly-Asp-Thr-Pro) and its negative control peptide RGE (Arg-Gly-Glu-Ser) for either 30 min followed by immunoprecipitation of cell lysates with anti-phosphotyrosine and Western immunoblotting with anti-FAK or for 24 h followed by cell counting, immunocytochemistry and flow cytometry. Both IGFBP-1 (0-800 ng/ml) and the synthetic RGD-containing peptide (1-100 microg/ml) caused significant dephosphorylation of FAK. Furthermore, after 24 h both peptides caused detachment from the matrix and the induction of apoptosis. We conclude from these data that IGFBP-1 can interact with integrin receptors to induce FAK dephosphorylation and subsequently influence attachment and cell death.

Signal transduction defects in growth hormone insensitivity

Growth hormone (GH) insensitivity is a heterogeneous condition that can result from mutations within the GH receptor (GHR) and that can be inherited as both an autosomal recessive and a dominant trait. However, evidence from a small number of growth hormone binding protein (GHBP)-positive families indicates that their GH insensitivity is independent of GHR mutations. Two of these families appear to have distinct abnormalities in GH signal transduction. Studies suggest that one family (classic Laron syndrome phenotype; designated family H) have a signalling defect close to the GHR, preventing activation of both the STAT and MAPK pathways, whereas the other family (less marked phenotype; family M) have a defect in activating MAPK but not the STAT pathway. The children studied here are specifically insensitive to GH and their defect must be exclusive to this signalling system. Thus, families with GHBP-positive GH insensitivity without GHR mutations are likely to be important models in which to study the specificity of GH signal transduction and the relationship between GH insensitive phenotype and signalling defect.

New growth hormone receptor exon 9 mutation causes genetic short stature

A novel form of congenital growth hormone insensitivity syndrome (GHIS), which lacks the classic phenotype associated with this condition, is described. Dominant inheritance is shown to result from a heterozygous 876-1 G to C transversion of the 3' splice acceptor site preceding exon 9 in the growth hormone receptor (GHR) gene. The result of this mutation is a severely truncated cytoplasmic domain of the GHR, which is incapable of transmitting a signal. The mutant receptor is shown to form a heterodimer with the wild-type GHR, the activity of which is inhibited in a dominant-negative manner.

Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency

(1) Deficiency of alpha AT is one of the most common hereditary diseases affecting Caucasians in Europe. The alpha 1AT protein is extremely pleomorphic, and around 90 variants due to mutations have been recognized. The prime functions of alpha 1AT is to inhibit neutrophil elastase, and a proportion of individuals who are deficient in alpha 1AT develop emphysema. The most common deficiency variant (Z) is also associated with liver disease. The main site of alpha 1AT synthesis is in the liver. Not all deficient individuals are affected by lung or liver disease, however, so that other factors (genetic and environmental) are clearly important. (2) Investigation of alpha 1AT status is essential in any child or adult presenting with chronic liver disease. The genetic cause cannot be identified clinically or by any other laboratory investigation. The diagnosis carries important prognostic consequences and is important for other family members. Patients with emphysema should have their Pi type determined, especially if they are under the age of 50, have never smoked or there is a suggestive family history. Asymptomatic individuals who are homozygous type Z should be referred to a chest physician for a clinical and radiological assessment together with lung function tests. (3) Several laboratory tests are available to detect alpha 1AT deficiency, and the choice of test(s) will depend on circumstances. Quantitation of the serum protein is simple and cheap. Because alpha 1AT is an acute phase protein, however, quantitation used in isolation may give false negative results which are clearly unacceptable, particularly in association with paediatric liver disease. Phenotyping by isoelectric focusing requires some experience in distinguishing SZ and ZZ phenotypes, and phenotyping should ideally be used in conjunction with quantitation because heterozygous null phenotypes may appear identical to homozygous normal phenotypes. (4) Prenatal diagnosis is usually performed by DNA analysis of CVS samples obtained at 11-13 weeks. Because of the risk that CVS samples might be contaminated by maternal tissue, assays which are less likely to detect minor contaminants are preferable. At present, use of DNA tests is confined to prenatal diagnosis, but the availability of simple tests and the possibility of unequivocal identification of S and Z alleles means that these tests are likely to find greater use in the near future.

Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome

Congenital GH insensitivity (Laron's syndrome, LS) is often associated with a dysfunctional GH receptor (GHR) causing complete insensitivity to GH and absent serum GH-binding protein (GHBP). However, a proportion of children with LS have normal GHBP levels. We have identified four girls from two families with this condition (height SD score, -3.4 to -6.8) and undertaken studies on 1) their GHR genes and 2) their GH responses in cultured skin fibroblasts to define the etiology of their GH insensitivities. No GHR gene mutations were identified in one family. In the other family, the affected siblings, an unaffected brother, and the father were heterozygous for a point mutation within exon 6 (D152H). In addition, use of intron 9 haplotypes to determine linkage to the GHR gene implied inheritance of different maternal GHR alleles in the two affected girls of the latter family. It is unlikely, therefore, that the D152H mutation alone could account for the LS phenotype. End points of GH action [DNA synthesis, insulin-like growth factor-binding protein-3 (IGFBP-3) messenger RNA (mRNA) and peptide production] in skin fibroblast cultures established from three of the LS subjects and four normal children were examined. Whereas normal fibroblasts incorporated [3H]thymidine dose dependently in response to 10-1000 ng/ml GH (increment at 1000 ng/ml, 77 +/- 19%), LS fibroblasts failed to respond significantly above basal levels (P < 0.01). In normal fibroblasts, IGFBP-3 mRNA and peptide increased maximally at 48 h in response to 200 ng/ml GH, as determined by ribonuclease protection assay, Western ligand blotting, and RIA. In comparison, LS fibroblasts produced significantly less IGFBP-3 peptide than normal fibroblasts in response to GH, whereas IGFBP-3 mRNA failed to increase above basal levels. These studies have shown that 1) cultured human skin fibroblasts can be used to define the end points of GH action; 2) fibroblast cultures from the LS children show absent or reduced responses to GH; and 3) GH insensitivity in these children does not appear to be caused exclusively by GHR mutations, but is probably due to dysfunctional GHR signalling. Such patients may prove particularly important to elucidation of the key events in GH signaling.